4.7 Article

The Transcription Factor Rfx3 Regulates β-Cell Differentiation, Function, and Glucokinase Expression

Journal

DIABETES
Volume 59, Issue 7, Pages 1674-1685

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/db09-0986

Keywords

-

Funding

  1. Swiss National Science Foundation
  2. Geneva Cancer League
  3. Swiss Multiple Sclerosis Society
  4. National Center of Competence in Research on Neural Plasticity and Repair (NCCR-NEURO)
  5. Boninchi Foundation
  6. Fondation Romande pour la Recherche sur le Diabete
  7. Roche Research Foundation
  8. Jules Thorne Foundation
  9. Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (ALFEDIAM)
  10. European Foundation for the Study of Diabetes (EFSD)
  11. Swiss National Science Foundation [310000-109402, CR3213129987, 3100A0-103867/1]
  12. Juvenile Diabetes Research Foundation [12007-158]
  13. EU [222980, C2008-T7]
  14. NIH/NIDDK [DK072522-01]
  15. NCCR Frontiers in Genetics

Ask authors/readers for more resources

OBJECTIVE-Pancreatic islets of perinatal mice lacking the transcription factor Rfx3 exhibit a marked reduction in insulin-producing beta-cells. The objective of this work was to unravel the cellular and molecular mechanisms underlying this deficiency. RESEARCH DESIGN AND METHODS-Immunofluorescence studies and quantitative RT-PCR experiments were used to study the emergence of insulin-positive cells, the expression of transcription factors implicated in the differentiation of beta-cells from endocrine progenitors, and the expression of mature beta-cell markers during development in Rfx3(-/-) and pancreas-specific Rfx3-knockout mice. RNA interference experiments were performed to document the consequences of downregulating Rfx3 expression in Min6 beta-cells. Quantitative chromatin immunoprecipitation (ChIP), ChIP sequencing, and bandshift experiments were used to identify Rfx3 target genes. RESULTS-Reduced development of insulin-positive cells in Rfx3(-/-) mice was not due to deficiencies in endocrine progenitors or beta-lineage specification, but reflected the accumulation of insulin-positive beta-cell precursors and defective beta-cells exhibiting reduced insulin, Glut-2, and Gck expression. Similar incompletely differentiated beta-cells developed in pancreas-specific Rfx3-deficient embryos. Defective beta-cells lacking Glut-2 and Gck expression dominate in Rfx3-deficent adults, leading to glucose intolerance. Attenuated Glut-2 and glucokinase expression, and impaired glucose-stimulated insulin secretion, were also induced by RNA interference-mediated inhibition of Rfx3 expression in Min6 cells. Finally, Rfx3 was found to bind in Min6 cells and human islets to two well-known regulatory sequences, Pal-1 and Pal-2, in the neuroendocrine promoter of the glucokinase gene. CONCLUSIONS-Our results show that Rfx3 is required for the differentiation and function of mature beta-cells and regulates the beta-cell promoter of the glucokinase gene. Diabetes 59:16741685, 2010

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available